RainEarth Inc. Releases 'Letter to the Shareholders'
28 Maggio 2009 - 6:00PM
PR Newswire (US)
BEIJING, May 28 /PRNewswire-Asia/ -- RainEarth Inc. (OTC: RNER)
(BULLETIN BOARD: RNER) ("the Company"), which recently changed its
name from Gold Rock Resources Inc. has released their Letter to the
shareholders to summarize the recent changes. "To our shareholders:
I would like to update you with the latest development of the
Company. On March 25, 2009, the Company and China RainEarth
Technology Co. Ltd., a company organized and existing under the
laws of the People's Republic of China ("China RainEarth"), entered
into a Business Cooperation Agreement (the "Agreement") for a term
of twenty years. The purpose of the Agreement is to jointly conduct
Hollow Fiber Membrane Materials' application and manufacturing
business in China. According to the Agreement, the Company will
provide Advice and assistance relating to development of marketing
and provision of consultancy services, particularly as related to
the Business to China RainEarth. China RainEarth will retain the
services and give 60% of its revenue after deduction of direct
operating costs, expenses and taxes to the Company in consideration
of the Company's services. The Company has changed name to
RainEarth Inc. to better reflect its current business. The
following questions and answers address briefly some questions you
may have regarding these changes. Q: What does China RainEarth do
for business? When did they establish? What are their
services/products? A: China RainEarth was established in October,
2005 in Beijing, China. China RainEarth is a hi-tech enterprise
which is dedicated to the research & development and
application of fiber membrane technologies. Developed independently
by China RainEarth, the techniques for manufacturing hollow fiber
membranes and fiber drawing equipment broke through foreign (mainly
German) technical monopoly, and gained supports from the Beijing
Innovation Fund for Small and Medium Enterprises in 2007, along
with the Beijing Municipal Science & Technology Commission and
the Innovation Fund for the 1st Batch of Small and Medium Technical
Enterprises in 2008, the fund was released from the Ministry of
Science and Technology in China. Q: What is hollow fiber membrane
technology? What is the application of such technology? A: Together
with nanotechnology, superconductivity and among others, separation
membrane technology is regarded as one of the top six industrial
high technologies in the 21st century. Over 70% of the chemical
industry is related to the separation membrane technology, which is
also fundamental to biological technologies. Hollow fiber
membranes, as a core component of special filtration absorbers, are
widely used in blood purification, ascites reinfusion and water
treatment, etc. Q: What is China RainEarth's product? What is the
market for this product? A: China RainEarth initially chose the
benchmark product blood dialyzer, which can best certify their
product research & development and manufacturing advantages, as
the market entry point, and then further entered ascites
concentrator and water purification markets. Blood dialysis is an
effective measure for patients with acute and chronic renal failure
(uremia) to sustain their lives. In 2007, 7-8 million pieces of
blood dialyzers were consumed in China. With the rapid social and
economic development as well as improvement of healthcare services,
15 million pieces of blood dialyzers will be consumed in China by
2012 and the market size will hit around US$200 million. 70 million
pieces of dialyzers are consumed each year in developing countries
including Turkey, India, South Africa and Pakistan. Q: What is
China RainEarth's advantage? What are China RainEarth's
qualifications? A: With 8 years of research and development by the
founders of China RainEarth, they have become the only company in
China that has mastered chemical formula and technique of hollow
fiber separation membranes as well as the design and development
capabilities for production equipment of hollow fiber separation
membranes. Currently their hollow fiber separation membrane has
passed China Compulsory Certification and tests by the State Food
and Drug Administration in China. Since China RainEarth has
proprietary fiber membrane manufacturing techniques (only German
Company: Fresenius can independently manufacture fiber membrane
production equipment) and the capabilities to design and develop
assembly and production lines, no need to import expensive
equipment, therefore, the products will have strong cost advantage.
Also, dialyzers manufactured by China RainEarth have undergone
clinical experiments and CCC certification, and obtained
registration certificates. China RainEarth has also completed all
tests and clinical experiments necessary for CE certification, and
is qualified to export its products. Q: What is China RainEarth's
current production capacity? A: Currently China RainEarth can
produce about 150,000 pieces of blood dialyzers annually from their
own facility. China RainEarth may lease other facilities to expand
the production capacity. Q: What is China RainEarth's development
objective? Long term and Short term? A: Long-term Development
Objective: China RainEarth will follow the success model of
Fresenius in Germany, to become a one stop shop producer and
service provider which include the entire industrial chain, and
will enter the extensive market of various filtering absorbers
through manufacturing hollow fibrous membrane products based on
patented hollow fibrous membrane technology and the design and
manufacturing technology of the membrane equipment. Short-term
Development Objective: It will begin with the manufacturing
technology of blood dialyzer and ascites concentrator, which is to
the best of China RainEarth's power and there are sufficient profit
margin and market capacity for these two products. Q: What is China
RainEarth's management team? A: Following are the brief
introductions about China RainEarth's management team: General
Manager: Mr. Liu Wei He has more than 15 years of work experience
in medicine and blood purification and several years of work
experience in market development and Mainland business affairs
management when working in "Song Ho" Company, the largest blood
purification group company in Japan and has participated in the
establishment of the first Sino-foreign cooperative hemodialysis
center in China. Technical Principal: Mr. Jiang Naiqing: He has
worked in the units of Dandong Chemical Fiber Plant, Ministry of
China Textile Industry, Beijing Chemical Fiber Plant, Beijing
Institute of Fashion Technology, etc. and specialized in the
research and development of chemical fibers. Since the year of
2000, he has committed himself to the research of hollow fiber
technology and has served as a General Engineer in Doreson Medical
in Shanghai, and designed and manufactured on his own a
polysulphone membrane hollow fiber spinning production line and a
matching dialyzer assembly line, which have come up to the level
for industrialized production, with them, real finished
products----dialyzers have been produced. Lead Engineer: Mr. Yu
Xuesong: He has more than 20 years of work experience in
mechanically and automatically controlled systems and has worked as
a Senior Engineer in the General Engineering Design & Research
Institute of the People's Liberation Army General Armament
Department to deal with mechanical-electrical integration and the
development and application of mechanically and automatically
controlled systems particularly. He has led the design and
development of the first "comprehensive blood purification
therapeutic machine" in China which is mainly used for treating
lupus erythematosus, immunological diseases like rheumatoid disease
and part of infectious diseases. Lead Engineer: Mr. Zhou Yue: He
has more than 20 years of work experience in
automatically-controlled system and high-voltage pulse field and
more than 15 years of experience in researching and developing
extracorporeal lithotripters, has led the design and development of
"shock-wave pain therapeutic-apparatus" and has the patent for
manufacturing special electrodes applied to the shock-wave pain
therapeutic-apparatus. Medical Adviser: Professor Wang Zhigang: He
is the Director of the Blood Purification Center of former
Friendship Hospital and an authoritative blood purification expert
in China. Technical Advisor: Professor Sun Benhui: He is a senior
professor and a doctoral tutor of Beijing University of Chemical
Technology and an authoritative expert in the field of membranes
for separation in China. Management Representative: Mr. Jiang Hua:
He is proficient on fibrous membrane production and has extensive
contact with the upstream and downstream enterprises of blood
purification industry. Q: What is RainEarth Inc's total outstanding
shares and total float? A: As of May 25, 2009, there are 52 million
total issued and outstanding shares, among it, 10 million is in the
float. This letter is for information purposes only. For more
detailed information, please read the Company's filings with SEC
and other press releases. Very truly yours, RainEarth Inc. By: /s/
Zhu, YongFu Zhu, YongFu President About the Company: RainEarth Inc.
(formerly Gold Rock Resources Inc., the "Company") was incorporated
in the State of Nevada on March 14, 2006. The Company is a
developing stage company that initially engages in the search for
mineral deposits or reserves. On March 25, 2009, the Company and
Beijing RainEarth Technology Co. Ltd., a company organized and
existing under the laws of the People's Republic of China, entered
into a Business Cooperation Agreement (the "Agreement") for a term
of twenty years. The purpose of the Agreement is to jointly conduct
Hollow Fiber Membrane Materials' application and manufacturing
business in China (the "Business"). The Company will provide Advice
and assistance relating to development of marketing and consultancy
services, particularly as related to the Business. Beijing
RainEarth Technology Co. Ltd. will give 60% of its revenue after
deduction of direct operating costs, expenses and taxes to the
Company in consideration of the Company's services. Forward-looking
statements This press release contains "forward-looking" statements
within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. All statements other than statements of historical facts
included in this press release are forward-looking statements.
Forward-looking statements involve risks and uncertainties
including, but not limited to, economic and political factors;
developments of the Chinese and North American markets and changes
in regulatory matters; our business strategies and future plans of
operations; the market acceptance and amount of sales of our
products and services; our historical losses; the competitive
environment within the industries in which we compete; and our
ability to raise additional capital, currently needed for
expansion. The Company cautions that forward-looking statements are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those indicated in the
forward-looking statements due to several important factors. For
more information, please contact: RainEarth Inc. Public
Relationship Department Tel: +86-10-6127-1736 DATASOURCE: RainEarth
Inc. CONTACT: RainEarth Inc., Public Relationship Department,
+86-10-6127-1736
Copyright